Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology

Background Postoperative radioactive iodine (RAI) administration is widely utilized in patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to recognize the potential negative sequelae of this treatment. The prevention, diagnosis, and management of the sal...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2020-11, Vol.42 (11), p.3446-3459
Main Authors: Singer, Michael C., Marchal, Francis, Angelos, Peter, Bernet, Vic, Boucai, Laura, Buchholzer, Samanta, Burkey, Brian, Eisele, David, Erkul, Evren, Faure, Frederic, Freitag, Suzanne K., Gillespie, Marion Boyd, Harrell, Richard Mack, Hartl, Dana, Haymart, Megan, Leffert, Jonathan, Mandel, Susan, Miller, Barbra S., Morris, John, Pearce, Elizabeth N., Rahmati, Rahmatullah, Ryan, William R., Schaitkin, Barry, Schlumberger, Martin, Stack, Brendan C., Van Nostrand, Doug, Wong, Ka Kit, Randolph, Gregory
Format: Article
Language:English
Subjects:
Complications
Endocrinology
Head & neck cancer
Iodine
lacrimal
Literature reviews
Nuclear medicine
Patients
radioactive iodine
recommendations
salivary
Salivary gland
Surgery
Thyroid cancer
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Postoperative radioactive iodine (RAI) administration is widely utilized in patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to recognize the potential negative sequelae of this treatment. The prevention, diagnosis, and management of the salivary and lacrimal complications of RAI exposure are addressed in this consensus statement. Methods A multidisciplinary panel of experts was convened under the auspices of the American Head and Neck Society Endocrine Surgery and Salivary Gland Sections. Following a comprehensive literature review to assess the current best evidence, this group developed six relevant consensus recommendations. Results Consensus recommendations on RAI were made in the areas of patient assessment, optimal utilization, complication prevention, and complication management. Conclusion Salivary and lacrimal complications secondary to RAI exposure are common and need to be weighed when considering its use. The recommendations included in this statement provide direction for approaches to minimize and manage these complications.
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.26417